Travel, lodging and meals reimbursed as a standard line in every trial budget
People should not have to pay to be in a trial. Sponsors would routinely cover travel, hotel and food costs, paid up front rather than claimed back, which is already accepted by regulators as fair rather than coercive.
Every trial budget includes a participant-cost line administered by a third party, prepaid where possible, covering travel, parking, lodging, meals and a companion. The FDA's position is that reimbursement for expenses is not undue influence. Charities such as the Lazarex Cancer Foundation have shown that covering these costs raises enrolment among low-income patients; the idea is to make sponsor funding of it universal, with ethics committees expecting it.
- Trials enrol too few, too slowly · Fewer than one in ten adults with cancer joins a trial. Trials close for lack of patients, not lack of ideas.
- Trials do not represent the people who get cancer · Older, Black, Hispanic, Asian, rural, poor and multimorbid patients are under-represented, so results may not apply to them.
Pages like this
not linked directly; found by shared links- IdeaPay trial participants for their time, not only their expenses
Shares Trials do not represent the people who get cancer, Trials enrol too few, too slowly.
- IdeaCommunity health workers and trusted local organisations paid to recruit for trials
Shares Trials do not represent the people who get cancer, Trials enrol too few, too slowly.
- IdeaAt least a third of pivotal-trial sites in community and rural settings
Shares Trials do not represent the people who get cancer, Trials enrol too few, too slowly.
- IdeaRemove blanket exclusions for mental illness and dementia; support consent instead
Shares Trials do not represent the people who get cancer, Trials enrol too few, too slowly.
- IdeaMobile research units bring trial visits to rural towns
Shares Trials do not represent the people who get cancer, Trials enrol too few, too slowly.
- IdeaDrop the 'must speak English' rule: translated consent and questionnaires as standard
Shares Trials do not represent the people who get cancer, Trials enrol too few, too slowly.
- IdeaLay trial navigators funded per centre, evaluated in a randomised trial
Shares Trials do not represent the people who get cancer, Trials enrol too few, too slowly.
- IdeaStop excluding people with a prior cancer, controlled HIV, or treated hepatitis
Shares Trials do not represent the people who get cancer, Trials enrol too few, too slowly.